SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-006733
Filing Date
2017-02-01
Accepted
2017-02-01 16:39:55
Documents
1
Period of Report
2017-01-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4990
  Complete submission text file 0001209191-17-006733.txt   6445
Mailing Address
Business Address
BASKETT FOREST (Reporting) CIK: 0001277631 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33882 | Film No.: 17565413

Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Cascadian Therapeutics, Inc. (Issuer) CIK: 0001412067 (see all company filings)

IRS No.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research